Amarin Corp Plc\uk (AMRN)
Amarin Corp Plc\uk on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
528K
Short interest
settlement 2026-09-30
10.5
Days to cover
+0.4 days vs prior
33.1%
Short share of volume
2026-10-23
65
Fails to deliver
settlement 2026-09-23
Wed 28 Oct
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in AMRN is 528,373 shares, up 17,371 shares over the last month. Over the last 48 readings it ranged from 341,942 shares (15 October 2025) to 18,719,684 shares (31 December 2024). The latest reading sits at the bottom of that range. At the reported average volume of 50K shares a day that is 10.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/amrn" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 528,373 | +0.5% | 50,129 | 10.54 |
| 2026-09-15 | 525,845 | +2.9% | 52,050 | 10.10 |
| 2026-08-31 | 511,002 | -2.8% | 109,653 | 4.66 |
| 2026-08-14 | 525,685 | -1.2% | 48,675 | 10.80 |
| 2026-07-31 | 532,113 | +3.7% | 54,453 | 9.77 |
| 2026-07-15 | 513,202 | -5.5% | 79,712 | 6.44 |
| 2026-06-30 | 542,861 | -11.5% | 102,584 | 5.29 |
| 2026-06-15 | 613,483 | -1.7% | 106,022 | 5.79 |
| 2026-05-29 | 624,093 | +0.6% | 42,027 | 14.85 |
| 2026-05-15 | 620,219 | -8.0% | 70,889 | 8.75 |
| 2026-04-30 | 673,967 | +57.9% | 94,148 | 7.16 |
| 2026-04-15 | 426,751 | -6.3% | 36,491 | 11.69 |
| 2026-03-31 | 455,457 | +1.9% | 44,989 | 10.12 |
| 2026-03-13 | 446,956 | +1.9% | 93,252 | 4.79 |
| 2026-02-27 | 438,392 | +6.9% | 92,991 | 4.71 |
| 2026-02-13 | 410,128 | -2.2% | 69,837 | 5.87 |
| 2026-01-30 | 419,315 | +2.4% | 89,726 | 4.67 |
| 2026-01-15 | 409,310 | -0.8% | 102,371 | 4.00 |
| 2025-12-31 | 412,528 | +1.4% | 93,347 | 4.42 |
| 2025-12-15 | 406,783 | -2.3% | 92,761 | 4.39 |
| 2025-11-28 | 416,191 | +5.5% | 73,726 | 5.65 |
| 2025-11-14 | 394,621 | +6.4% | 102,707 | 3.84 |
| 2025-10-31 | 370,983 | +8.5% | 174,534 | 2.13 |
| 2025-10-15 | 341,942 | -8.8% | 123,030 | 2.78 |
| 2025-09-30 | 374,988 | -7.6% | 71,269 | 5.26 |
| 2025-09-15 | 405,739 | -4.6% | 49,102 | 8.26 |
| 2025-08-29 | 425,212 | -0.1% | 58,468 | 7.27 |
| 2025-08-15 | 425,407 | -10.8% | 70,401 | 6.04 |
| 2025-07-31 | 476,647 | +15.2% | 65,901 | 7.23 |
| 2025-07-15 | 413,785 | -7.7% | 114,826 | 3.60 |
| 2025-06-30 | 448,322 | +4.3% | 230,606 | 1.94 |
| 2025-06-13 | 430,048 | -13.8% | 131,908 | 3.26 |
| 2025-05-30 | 499,034 | -10.6% | 52,083 | 9.58 |
| 2025-05-15 | 558,376 | +18.3% | 98,550 | 5.67 |
| 2025-04-30 | 472,004 | -25.0% | 99,259 | 4.76 |
| 2025-04-15 | 629,443 | -94.7% | 130,462 | 4.82 |
| 2025-03-31 | 11,971,026 | +10.5% | 1,268,309 | 9.44 |
| 2025-03-14 | 10,837,604 | -35.5% | 2,990,648 | 3.62 |
| 2025-02-28 | 16,789,166 | -1.5% | 693,626 | 24.20 |
| 2025-02-14 | 17,045,955 | +1.2% | 1,086,828 | 15.68 |
| 2025-01-31 | 16,847,612 | -2.0% | 1,100,682 | 15.31 |
| 2025-01-15 | 17,186,993 | -8.2% | 1,305,522 | 13.16 |
| 2024-12-31 | 18,719,684 | +2.9% | 2,255,567 | 8.30 |
| 2024-12-13 | 18,190,540 | +1.4% | 1,621,100 | 11.22 |
| 2024-11-29 | 17,948,640 | +0.1% | 1,627,963 | 11.03 |
| 2024-11-15 | 17,928,735 | -0.1% | 1,168,842 | 15.34 |
| 2024-10-31 | 17,948,018 | -0.7% | 1,033,614 | 17.36 |
| 2024-10-15 | 18,080,528 | +1.2% | 757,519 | 23.87 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of AMRN volume is 33.1%, down 6.9 points over the last five sessions. Over the last 30 readings it ranged from 20.6% (15 October 2026) to 63.5% (23 September 2026). The latest reading is 9.9 points below the 30-session average of 43.1%, on 37K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 12K | 37K | 33.1% | 135 |
| 2026-10-22 | 5K | 13K | 36.2% | 0 |
| 2026-10-21 | 6K | 12K | 50.8% | 25 |
| 2026-10-20 | 6K | 11K | 51.4% | 3 |
| 2026-10-19 | 19K | 44K | 43.7% | 0 |
| 2026-10-16 | 16K | 39K | 40.1% | 0 |
| 2026-10-15 | 6K | 28K | 20.6% | 0 |
| 2026-10-14 | 10K | 25K | 40.5% | 0 |
| 2026-10-13 | 28K | 56K | 50.5% | 0 |
| 2026-10-12 | 12K | 35K | 35.6% | 10 |
| 2026-10-09 | 3K | 10K | 27.2% | 0 |
| 2026-10-08 | 11K | 18K | 62.1% | 0 |
| 2026-10-07 | 14K | 36K | 37.4% | 0 |
| 2026-10-06 | 13K | 29K | 45.7% | 0 |
| 2026-10-05 | 12K | 31K | 37.2% | 0 |
| 2026-10-02 | 21K | 44K | 47.0% | 446 |
| 2026-10-01 | 6K | 26K | 24.5% | 0 |
| 2026-09-30 | 7K | 29K | 25.2% | 0 |
| 2026-09-29 | 4K | 7K | 54.2% | 0 |
| 2026-09-28 | 5K | 11K | 45.9% | 0 |
| 2026-09-25 | 23K | 58K | 39.4% | 100 |
| 2026-09-24 | 5K | 10K | 49.3% | 0 |
| 2026-09-23 | 17K | 26K | 63.5% | 35 |
| 2026-09-22 | 15K | 36K | 42.3% | 0 |
| 2026-09-21 | 9K | 17K | 55.9% | 0 |
| 2026-09-18 | 11K | 21K | 52.5% | 280 |
| 2026-09-17 | 6K | 12K | 53.0% | 0 |
| 2026-09-16 | 7K | 16K | 42.5% | 0 |
| 2026-09-15 | 9K | 18K | 51.2% | 0 |
| 2026-09-14 | 5K | 14K | 33.5% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 23 September 2026, the fails-to-deliver balance in AMRN is 65 shares, up 31 shares over the last settlement date. Over the last 30 readings it ranged from 16 shares (20 May 2026) to 2,748 shares (5 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-23 | 65 | $13.75 | $894 |
| 2026-09-08 | 34 | $13.63 | $463 |
| 2026-08-28 | 577 | $14.07 | $8K |
| 2026-08-13 | 151 | $14.06 | $2K |
| 2026-08-06 | 273 | $14.41 | $4K |
| 2026-07-27 | 87 | $13.55 | $1K |
| 2026-07-22 | 99 | $13.93 | $1K |
| 2026-06-25 | 89 | $16.41 | $1K |
| 2026-06-23 | 269 | $15.81 | $4K |
| 2026-06-22 | 735 | $16.03 | $12K |
| 2026-06-18 | 1,457 | $15.77 | $23K |
| 2026-06-17 | 618 | $15.17 | $9K |
| 2026-06-16 | 174 | $15.35 | $3K |
| 2026-06-05 | 2,748 | $13.80 | $38K |
| 2026-06-04 | 2,108 | $14.53 | $31K |
| 2026-06-03 | 2,607 | $14.47 | $38K |
| 2026-06-02 | 1,904 | $14.36 | $27K |
| 2026-06-01 | 577 | $14.49 | $8K |
| 2026-05-29 | 326 | $14.41 | $5K |
| 2026-05-27 | 82 | $14.30 | $1K |
| 2026-05-20 | 16 | $14.05 | $225 |
| 2026-05-19 | 129 | $14.06 | $2K |
| 2026-05-18 | 664 | $14.56 | $10K |
| 2026-05-15 | 75 | $14.78 | $1K |
| 2026-05-13 | 62 | $14.95 | $927 |
| 2026-05-12 | 121 | $15.02 | $2K |
| 2026-05-11 | 119 | $15.05 | $2K |
| 2026-05-08 | 153 | $14.84 | $2K |
| 2026-05-07 | 208 | $14.90 | $3K |
| 2026-05-06 | 80 | $14.50 | $1K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for AMRN in the last 90 days. The most recent filings are listed below. Latest filing: Fishman Peter L. (SVP, CFO) on 2026-08-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-01 | Fishman Peter L. | SVP, CFO | Tax withholding | 155 | $14.26 | $2K | 8K |
| 2026-08-01 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 313 | price not stated in the filing | not stated | 8K |
| 2026-07-01 | Fishman Peter L. | SVP, CFO | Tax withholding | 1K | $15.94 | $19K | 7K |
| 2026-07-01 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 2K | price not stated in the filing | not stated | 9K |
| 2026-07-01 | Keenan David Paul | EVP, Chief Operating Officer | Tax withholding | 2K | $15.94 | $31K | 13K |
| 2026-07-01 | Keenan David Paul | EVP, Chief Operating Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 15K |
| 2026-07-01 | Ketchum Steven B | EVP, Chief Scientific Officer | Tax withholding | 2K | $15.94 | $30K | 43K |
| 2026-07-01 | Ketchum Steven B | EVP, Chief Scientific Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 45K |
| 2026-07-01 | Provoost Jonathan | EVP, Chief Legal Officer | Tax withholding | 1K | $15.94 | $20K | 5K |
| 2026-07-01 | Provoost Jonathan | EVP, Chief Legal Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 6K |
| 2026-06-26 | Berg Aaron | President and CEO | Tax withholding | 3K | $16.35 | $52K | 86K |
| 2026-06-26 | Berg Aaron | President and CEO | Exercise or conversion | 6K | price not stated in the filing | not stated | 89K |
| 2026-04-18 | O'Connor Oliver | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 1K |
| 2026-04-18 | O'Connor Oliver | Director | Tax withholding | 438 | $14.98 | $7K | 801 |
| 2026-04-18 | Sullivan Diane E. | Director | Tax withholding | 403 | $14.98 | $6K | 836 |
| 2026-04-18 | Sullivan Diane E. | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 1K |
| 2026-04-18 | Sterling Louis III | Director | Tax withholding | 403 | $14.98 | $6K | 4K |
| 2026-04-18 | Sterling Louis III | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 4K |
| 2026-04-18 | Cohen Paul | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 1K |
| 2026-04-18 | Cohen Paul | Director | Tax withholding | 403 | $14.98 | $6K | 836 |
| 2026-04-18 | Horn Keith | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 1K |
| 2026-04-18 | Horn Keith | Director | Tax withholding | 403 | $14.98 | $6K | 836 |
| 2026-04-18 | Odysseas Kostas D | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 1K |
| 2026-04-18 | Odysseas Kostas D | Director | Tax withholding | 403 | $14.98 | $6K | 836 |
| 2026-04-18 | Bonfiglio Patrice Eadon | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 1K |
| 2026-04-18 | Bonfiglio Patrice Eadon | Director | Tax withholding | 403 | $14.98 | $6K | 836 |
| 2026-04-01 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 125 | price not stated in the filing | not stated | 6K |
| 2026-04-01 | Fishman Peter L. | SVP, CFO | Tax withholding | 62 | $14.46 | $897 | 6K |
| 2026-01-31 | Keenan David Paul | EVP, Chief Operating Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 12K |
| 2026-01-31 | Keenan David Paul | EVP, Chief Operating Officer | Tax withholding | 1K | $15.42 | $18K | 11K |
| 2026-01-31 | Keenan David Paul | EVP, Chief Operating Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 13K |
| 2026-01-31 | Keenan David Paul | EVP, Chief Operating Officer | Tax withholding | 1K | $15.42 | $16K | 12K |
| 2026-01-31 | Fishman Peter L. | SVP, CFO | Tax withholding | 1K | $15.42 | $16K | 6K |
| 2026-01-31 | Fishman Peter L. | SVP, CFO | Tax withholding | 310 | $15.42 | $5K | 5K |
| 2026-01-31 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 2K | price not stated in the filing | not stated | 7K |
| 2026-01-31 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 563 | price not stated in the filing | not stated | 6K |
| 2026-01-31 | Berg Aaron | President and CEO | Exercise or conversion | 2K | price not stated in the filing | not stated | 84K |
| 2026-01-31 | Berg Aaron | President and CEO | Tax withholding | 1K | $15.42 | $16K | 83K |
| 2026-01-31 | Berg Aaron | President and CEO | Tax withholding | 1K | $15.42 | $19K | 82K |
| 2026-01-31 | Berg Aaron | President and CEO | Exercise or conversion | 2K | price not stated in the filing | not stated | 83K |
| 2026-01-31 | Ketchum Steven B | EVP, Chief Scientific Officer | Tax withholding | 1K | $15.42 | $16K | 41K |
| 2026-01-31 | Ketchum Steven B | EVP, Chief Scientific Officer | Tax withholding | 1K | $15.42 | $19K | 40K |
| 2026-01-31 | Ketchum Steven B | EVP, Chief Scientific Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 41K |
| 2026-01-31 | Ketchum Steven B | EVP, Chief Scientific Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 42K |
| 2026-01-02 | Ketchum Steven B | EVP, Chief Scientific Officer | Tax withholding | 2K | $13.96 | $28K | 39K |
| 2026-01-02 | Ketchum Steven B | EVP, Chief Scientific Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 41K |
| 2026-01-02 | Provoost Jonathan | EVP, Chief Legal Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 4K |
| 2026-01-02 | Provoost Jonathan | EVP, Chief Legal Officer | Tax withholding | 1K | $13.96 | $21K | 2K |
| 2026-01-02 | Keenan David Paul | EVP, Chief Operating Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 12K |
| 2026-01-02 | Keenan David Paul | EVP, Chief Operating Officer | Tax withholding | 2K | $13.96 | $27K | 10K |
| 2026-01-02 | Fishman Peter L. | SVP, CFO | Tax withholding | 1K | $13.96 | $19K | 5K |
| 2026-01-02 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 2K | price not stated in the filing | not stated | 6K |
| 2025-08-01 | Fishman Peter L. | SVP, CFO | Tax withholding | 160 | $14.52 | $2K | 4K |
| 2025-08-01 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 312 | price not stated in the filing | not stated | 4K |
| 2025-06-26 | Berg Aaron | President and CEO | Tax withholding | 38K | $15.90 | $610K | 81K |
| 2025-06-26 | Berg Aaron | President and CEO | Exercise or conversion | 75K | price not stated in the filing | not stated | 119K |
| 2025-04-18 | DiPaolo Mark | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 838 |
| 2025-04-18 | DiPaolo Mark | Director | Tax withholding | 437 | $9.11 | $4K | 401 |
| 2025-04-18 | O'Connor Oliver | Director | Tax withholding | 437 | $9.11 | $4K | 401 |
| 2025-04-18 | O'Connor Oliver | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 838 |
| 2025-04-18 | Sterling Louis III | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 4K |
| 2025-04-18 | Sterling Louis III | Director | Tax withholding | 437 | $9.11 | $4K | 4K |
| 2025-04-18 | Sullivan Diane E. | Director | Tax withholding | 437 | $9.11 | $4K | 401 |
| 2025-04-18 | Sullivan Diane E. | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 838 |
| 2025-04-18 | Odysseas Kostas D | Director | Tax withholding | 437 | $9.11 | $4K | 401 |
| 2025-04-18 | Odysseas Kostas D | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 838 |
| 2025-04-18 | Bonfiglio Patrice Eadon | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 838 |
| 2025-04-18 | Bonfiglio Patrice Eadon | Director | Tax withholding | 437 | $9.11 | $4K | 401 |
| 2025-04-18 | Horn Keith | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 838 |
| 2025-04-18 | Horn Keith | Director | Tax withholding | 437 | $9.11 | $4K | 401 |
| 2025-04-18 | Cohen Paul | Director | Exercise or conversion | 838 | price not stated in the filing | not stated | 838 |
| 2025-04-18 | Cohen Paul | Director | Tax withholding | 437 | $9.11 | $4K | 401 |
| 2025-04-01 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 3K | price not stated in the filing | not stated | 78K |
| 2025-04-01 | Fishman Peter L. | SVP, CFO | Tax withholding | 857 | $0.65 | $557 | 77K |
| 2025-03-01 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 3K | price not stated in the filing | not stated | 76K |
| 2025-03-01 | Fishman Peter L. | SVP, CFO | Tax withholding | 891 | $0.63 | $561 | 75K |
| 2025-01-31 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 8K | price not stated in the filing | not stated | 57K |
| 2025-01-31 | Fishman Peter L. | SVP, CFO | Tax withholding | 5K | $0.62 | $3K | 52K |
| 2025-01-31 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 11K | price not stated in the filing | not stated | 63K |
| 2025-01-31 | Fishman Peter L. | SVP, CFO | Tax withholding | 6K | $0.62 | $4K | 57K |
| 2025-01-31 | Fishman Peter L. | SVP, CFO | Exercise or conversion | 37K | price not stated in the filing | not stated | 94K |
| 2025-01-31 | Fishman Peter L. | SVP, CFO | Tax withholding | 20K | $0.62 | $13K | 73K |
| 2025-01-31 | Berg Aaron | President and CEO | Exercise or conversion | 35K | price not stated in the filing | not stated | 863K |
| 2025-01-31 | Berg Aaron | President and CEO | Tax withholding | 19K | $0.62 | $12K | 844K |
| 2025-01-31 | Berg Aaron | President and CEO | Exercise or conversion | 45K | price not stated in the filing | not stated | 889K |
| 2025-01-31 | Berg Aaron | President and CEO | Tax withholding | 25K | $0.62 | $15K | 864K |
| 2025-01-31 | Berg Aaron | President and CEO | Tax withholding | 21K | $0.62 | $13K | 882K |
| 2025-01-31 | Berg Aaron | President and CEO | Exercise or conversion | 39K | price not stated in the filing | not stated | 903K |
| 2025-01-31 | Ketchum Steven B | Chief Scientific Officer | Tax withholding | 21K | $0.62 | $13K | 747K |
| 2025-01-31 | Ketchum Steven B | Chief Scientific Officer | Exercise or conversion | 39K | price not stated in the filing | not stated | 768K |
| 2025-01-31 | Ketchum Steven B | Chief Scientific Officer | Tax withholding | 25K | $0.62 | $15K | 729K |
| 2025-01-31 | Ketchum Steven B | Chief Scientific Officer | Exercise or conversion | 45K | price not stated in the filing | not stated | 754K |
| 2025-01-31 | Ketchum Steven B | Chief Scientific Officer | Tax withholding | 19K | $0.62 | $12K | 709K |
| 2025-01-31 | Ketchum Steven B | Chief Scientific Officer | Exercise or conversion | 35K | price not stated in the filing | not stated | 729K |
| 2025-01-30 | Berg Aaron | President and CEO | Tax withholding | 28K | $0.62 | $18K | 828K |
| 2025-01-30 | Berg Aaron | President and CEO | Exercise or conversion | 52K | price not stated in the filing | not stated | 857K |
| 2025-01-30 | Ketchum Steven B | Chief Scientific Officer | Tax withholding | 28K | $0.62 | $18K | 694K |
| 2025-01-30 | Ketchum Steven B | Chief Scientific Officer | Exercise or conversion | 52K | price not stated in the filing | not stated | 722K |
| 2024-08-02 | Berg Aaron | President and CEO | Buy | 160K | $0.64 | $102K | 805K |
| 2024-07-31 | Berg Aaron | President and CEO | Exercise or conversion | 24K | price not stated in the filing | not stated | 657K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of AMRN in their latest filing, all on Schedule 13D (active intent). The largest reported stake is Sarissa Capital Management LP at 6.1% of the class (25,743,900 shares), filed 2026-08-27 for an event on 2026-08-25.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-27 | 13D/Ano. 16 | Sarissa Capital Management LPpartnership | 25.7M | 6.1% | 2026-08-25 |
| 2026-08-27 | 13D/Ano. 16 | Alexander J Dennerindividual | 25.7M | 6.1% | 2026-08-25 |
13F holders
Tracked managers holding AMRN at their latest 13F. JSON4 of the 30 tracked managers held AMRN at their latest 13F, $5.7M in total at quarter-end prices. Millennium Management is the largest at $1.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 116K | $1.8M | 0.00% | -185K |
| Two Sigma Investments | 2026-06-30 | 101K | $1.6M | 0.00% | -7K |
| Citadel Advisors | 2026-06-30 | 95K | $1.5M | 0.00% | +15K |
| Renaissance Technologies | 2026-06-30 | 48K | $771K | 0.00% | +29K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Amarin Corp Plc\uk reported revenue of $42.2M, down 42.0% from the same quarter a year earlier, and net loss of $7.7M (-0.02 diluted EPS). In FY 2025 it generated $6.7M of operating cash flow.
- Cash
- $143.6M
- Equity
- $443.6M
- Total assets
- $624.4M
- Shares outstanding
- 380,694
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $42.2M | -$7.7M | -18.1% | -0.02 |
| Q1 FY 2026 | 2026-03-31 | $45.1M | -$10.5M | -23.3% | -0.03 |
| Q4 FY 2025derived | 2025-12-31 | $49.2M | -$1.2M | -2.5% | n/a |
| Q3 FY 2025 | 2025-09-30 | $49.7M | -$7.7M | -15.6% | -0.02 |
| Q2 FY 2025 | 2025-06-30 | $72.7M | -$14.1M | -19.4% | -0.03 |
| Q1 FY 2025 | 2025-03-31 | $42.0M | -$15.7M | -37.4% | -0.04 |
| Q4 FY 2024derived | 2024-12-31 | $62.3M | -$48.6M | -78.0% | n/a |
| Q3 FY 2024 | 2024-09-30 | $42.3M | -$25.1M | -59.4% | -0.06 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $213.6M | -$38.8M | $6.7M | n/a | n/a | n/a |
| FY 2024 | 2024-12-31 | $228.6M | -$82.2M | -$31.0M | n/a | n/a | n/a |
| FY 2023 | 2023-12-31 | $306.9M | -$59.1M | $6.9M | n/a | n/a | n/a |
| FY 2022 | 2022-12-31 | $369.2M | -$105.8M | -$180.1M | n/a | n/a | n/a |
| FY 2021 | 2021-12-31 | $583.2M | $7.7M | -$66.5M | n/a | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2013-02-20 from the cover page.
What this page is
Amarin Corp Plc\uk in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Amarin Corp Plc\uk (AMRN), SEC CIK 897448, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-23.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-27.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-29.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 897448Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
Datasets
Frequently Asked Questions
How much of AMRN is sold short?
What is AMRN's daily short volume?
Does AMRN have fails to deliver?
Are AMRN insiders buying or selling?
Who owns 5% or more of AMRN?
What did AMRN report last quarter?
Which tracked 13F managers own AMRN?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.